Shares dropped 14% as investors signaled disappointment with the lack of clear outlook visibility and uneven sales momentum despite solid margin expansion and modest growth. The cautious tone on sales patterns and ongoing SG&A headwinds amid acquisition-related cost pressure weighed on confidence.
DXP Enterprises delivered robust Q3 2025 results with total sales up 8.6% year-over-year, propelled by strong demand across key segments and a notable 11% adjusted EBITDA margin.